Showing results (671-680 of 2,947) with videos related to

Sort By:
Pageof 295
Molecular and Clinical Oncology|October 15, 2025
Taking the 'low' into consideration: Discussions on redefining HER2 status in breast cancer (Review)Alexandros Georgiou, Evangelia Anna Spiteri, Demetrios A Spandidos, et al.
Molecular and Clinical Oncology|May 15, 2025
Low prealbumin level is a poor prognostic biomarker for surgically treated pancreatic cancerYu Matsumoto, Yuichiro Otsuka, Hiroka Hosaka, et al.
Molecular and Clinical Oncology|July 22, 2025
Clinical and therapeutic insights into intraventricular metastases from extracranial solid tumors: Patterns, prognosis and managementNaveen Arunachalam Sakthiyendran, Daniel Sconzo, Aryan Wadhwa, et al.
Molecular and Clinical Oncology|May 5, 2025
Peripheral biomarkers predict survival in patients with glioblastoma treated with temozolomideShuodan Zhang, Nadia McMillan, Matthew McGuinness, et al.
Molecular and Clinical Oncology|May 5, 2025
Bevacizumab‑associated intracerebral hemorrhage in patients with malignant gliomaYuya Hama, Takahiro Sasaki, Junya Fukai, et al.
Molecular and Clinical Oncology|September 29, 2025
Clinical manifestation and pathological changes of serous papillary adenofibroma: A case seriesXiaojing Zhao, Chaoyi Yuan, Xinrun Wang, et al.
Molecular and Clinical Oncology|September 29, 2025
Association of cesarean section with breast cancer: A systematic review and meta-analysisFoteini Stamou, Anastasia Bothou, Giannoula Kyrkou, et al.
Molecular and Clinical Oncology|January 29, 2026
Reduction of seroma by pectoralis fascia dissection using an energy device in total mastectomy for breast cancer: An observational studyHiroaki Shima, Yuta Kondo, Takashi Nakamura, et al.
Molecular and Clinical Oncology|August 4, 2025
Staphylococcal nuclease and tudor domain-containing protein 1: An emerging therapeutic target in cancer (Review)Santosh Kumar Rai, Mohd Imran Khan, Rakesh Kumar, et al.
Molecular and Clinical Oncology|June 18, 2025
Extended progression-free survival after combination treatment with anlotinib and S-1 in refractory advanced esophageal cancer: A case reportJinsong Yang, Cui Liu, Li Liu, et al.
Pageof 295